The human papillomavirous (HPV) is a group of more than 150 related viruses. Each HPV virus in this large group is given a number which is called its HPV type. HPV is named for the warts (papillomas) some HPV types can cause. The human papillomavirus (HPV) infection poses a major public health threat in the United States. According to the Center for Disease Control and Prevention (CDC), about 79 million Americans are currently infected with human papillomavirus, and 14 million people become newly infected each year. HPV is the most common sexually transmitted disease among men and women between the ages of 14 and 25 (NIH). Considering that it is the leading cause of cervical cancer and the staggering number of people infected, the CDC declared
…show more content…
According to Laia Bruni et al. in the article “Cervical HPV Prevalence in five Continents: Meta-Analysis of 1 Million Women with Normal Cytological Findings,” Sub-Saharan Africa estimated prevalence is 24 percent, Eastern Europe 21.4%, Latin America and the Caribbean 16.1%, Southeastern Asia 14% and North American region 10.2%. (Bruni el at.). J. Burdach PhD in his article titled “Human Papilloma Viruses: New challenges for Infection Prevention, postulates a number of lines of evidence that support the risk of transmission in the clinical setting. First, “that HPV is resistant to desiccation and can remain infectious when exposed to a typical dry room environment for a number of days; HPV DNA has been detected on the fingers of individuals with an active infection, showing that infected patients can carry the virus on their hands and act as a source of infectious virions, and there is evidence that HPV can be transmitted via touch, as low-risk HPV infection by self-inoculation has been documented in children in cases where no signs of sexual abuse can explain the transmission of genital warts.” In 2006, Merck, a U.S. company developed HPV vaccine, called Gardasil. The purpose of the vaccine is to prevent females from contracting cervical cancer and is most effective when given prior to the female becoming sexually active.
According to Laia Bruni et al. in the article “Cervical HPV Prevalence in five Continents: Meta-Analysis of 1 Million Women with Normal Cytological Findings,” Sub-Saharan Africa estimated prevalence is 24 percent, Eastern Europe 21.4%, Latin America and the Caribbean 16.1%, Southeastern Asia 14% and North American region 10.2%. (Bruni el at.). J. Burdach PhD in his article titled “Human Papilloma Viruses: New challenges for Infection Prevention, postulates a number of lines of evidence that support the risk of transmission in the clinical setting. First, “that HPV is resistant to desiccation and can remain infectious when exposed to a typical dry room environment for a number of days; HPV DNA has been detected on the fingers of individuals with an active infection, showing that infected patients can carry the virus on their hands and act as a source of infectious virions, and there is evidence that HPV can be transmitted via touch, as low-risk HPV infection by self-inoculation has been documented in children in cases where no signs of sexual abuse can explain the transmission of genital warts.” In 2006, Merck, a U.S. company developed HPV vaccine, called Gardasil. The purpose of the vaccine is to prevent females from contracting cervical cancer and is most effective when given prior to the female becoming sexually active.